{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:01:49Z","timestamp":1791000109588,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["MB 453012513"],"award-info":[{"award-number":["MB 453012513"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["PO 716\/11-1, PO 716\/14-1"],"award-info":[{"award-number":["PO 716\/11-1, PO 716\/14-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KI2006D, 01KI20328A, 01KX2021"],"award-info":[{"award-number":["01KI2006D, 01KI20328A, 01KX2021"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011937","name":"Nieders\u00e4chsische Ministerium f\u00fcr Wissenschaft und Kultur","doi-asserted-by":"publisher","award":["14-76103-184, COFONI Network, including projects 7FF22, 6FF22, 10FF22"],"award-info":[{"award-number":["14-76103-184, COFONI Network, including projects 7FF22, 6FF22, 10FF22"]}],"id":[{"id":"10.13039\/100011937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["UNDINE"],"award-info":[{"award-number":["UNDINE"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The SARS-CoV-2 Omicron subvariants BA.1 and BA.2 exhibit reduced lung cell infection relative to previously circulating SARS-CoV-2 variants, which may account for their reduced pathogenicity. However, it is unclear whether lung cell infection by BA.5, which displaced these variants, remains attenuated. Here, we show that the spike (S) protein of BA.5 exhibits increased cleavage at the S1\/S2 site and drives cell-cell fusion and lung cell entry with higher efficiency than its counterparts from BA.1 and BA.2. Increased lung cell entry depends on mutation H69\u0394\/V70\u0394 and is associated with efficient replication of BA.5 in cultured lung cells. Further, BA.5 replicates in the lungs of female Balb\/c mice and the nasal cavity of female ferrets with much higher efficiency than BA.1. These results suggest that BA.5 has acquired the ability to efficiently infect lung cells, a prerequisite for causing severe disease, suggesting that evolution of Omicron subvariants can result in partial loss of attenuation.<\/jats:p>","DOI":"10.1038\/s41467-023-39147-4","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T16:02:27Z","timestamp":1686672147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Omicron subvariant BA.5 efficiently infects lung cells"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4603-7696","authenticated-orcid":false,"given":"Markus","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lok-Yin Roy","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prerna","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheila","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby","family":"Odle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8752-7491","authenticated-orcid":false,"given":"Inga","family":"Nehlmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Kempf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7983-2808","authenticated-orcid":false,"given":"Nico Joel","family":"Halwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Sch\u00f6n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5004-806X","authenticated-orcid":false,"given":"Lorenz","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4552-031X","authenticated-orcid":false,"given":"Donata","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0598-5254","authenticated-orcid":false,"given":"Martin","family":"Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7923-0519","authenticated-orcid":false,"given":"Christian","family":"Drosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4213-2354","authenticated-orcid":false,"given":"Stanley","family":"Perlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6086-9136","authenticated-orcid":false,"given":"Stefan","family":"P\u00f6hlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,13]]},"reference":[{"key":"39147_CR1","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S1473-3099(22)00224-9","volume":"22","author":"P Arora","year":"2022","unstructured":"Arora, P. et al. Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3. Lancet Infect. Dis. 22, 766\u2013767 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"39147_CR2","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/s41586-021-04386-2","volume":"602","author":"E Cameroni","year":"2022","unstructured":"Cameroni, E. et al. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. Nature 602, 664\u2013670 (2022).","journal-title":"Nature"},{"key":"39147_CR3","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cell.2021.12.032","volume":"185","author":"M Hoffmann","year":"2022","unstructured":"Hoffmann, M. et al. The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic. Cell 185, 447\u2013456.e411 (2022).","journal-title":"Cell"},{"key":"39147_CR4","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41586-022-04594-4","volume":"604","author":"S Iketani","year":"2022","unstructured":"Iketani, S. et al. Antibody evasion properties of SARS-CoV-2 Omicron sublineages. Nature 604, 553\u2013556 (2022).","journal-title":"Nature"},{"key":"39147_CR5","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41586-021-04388-0","volume":"602","author":"L Liu","year":"2022","unstructured":"Liu, L. et al. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2. Nature 602, 676\u2013681 (2022).","journal-title":"Nature"},{"key":"39147_CR6","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1056\/NEJMp2119682","volume":"386","author":"RP Bhattacharyya","year":"2022","unstructured":"Bhattacharyya, R. P. & Hanage, W. P. Challenges in inferring intrinsic severity of the SARS-CoV-2 Omicron variant. N. Engl. J. Med. 386, e14 (2022).","journal-title":"N. Engl. J. Med."},{"key":"39147_CR7","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0140-6736(22)00017-4","volume":"399","author":"N Wolter","year":"2022","unstructured":"Wolter, N. et al. Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study. Lancet 399, 437\u2013446 (2022).","journal-title":"Lancet"},{"key":"39147_CR8","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41586-022-04479-6","volume":"603","author":"KPY Hui","year":"2022","unstructured":"Hui, K. P. Y. et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature 603, 715\u2013720 (2022).","journal-title":"Nature"},{"key":"39147_CR9","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","volume":"603","author":"B Meng","year":"2022","unstructured":"Meng, B. et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature 603, 706\u2013714 (2022).","journal-title":"Nature"},{"key":"39147_CR10","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-022-04442-5","volume":"603","author":"H Shuai","year":"2022","unstructured":"Shuai, H. et al. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron. Nature 603, 693\u2013699 (2022).","journal-title":"Nature"},{"key":"39147_CR11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/22221751.2021.2023329","volume":"11","author":"H Zhao","year":"2022","unstructured":"Zhao, H. et al. SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells. Emerg. Microbes Infect. 11, 277\u2013283 (2022).","journal-title":"Emerg. Microbes Infect."},{"key":"39147_CR12","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41586-022-04462-1","volume":"603","author":"R Suzuki","year":"2022","unstructured":"Suzuki, R. et al. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Nature 603, 700\u2013705 (2022).","journal-title":"Nature"},{"key":"39147_CR13","unstructured":"Tegally, H. et al. Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa. Nat. Med. 28, 1785\u20131790 (2022)."},{"key":"39147_CR14","doi-asserted-by":"publisher","first-page":"106698","DOI":"10.1016\/j.ijsu.2022.106698","volume":"103","author":"RK Mohapatra","year":"2022","unstructured":"Mohapatra, R. K. et al. The recently emerged BA.4 and BA.5 lineages of Omicron and their global health concerns amid the ongoing wave of COVID-19 pandemic - Correspondence. Int. J. Surg. 103, 106698 (2022).","journal-title":"Int. J. Surg."},{"key":"39147_CR15","doi-asserted-by":"crossref","unstructured":"Bestle, D. et al. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells. Life Sci. Alliance 3, e202000786 (2020).","DOI":"10.26508\/lsa.202000786"},{"key":"39147_CR16","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.molcel.2020.04.022","volume":"78","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M., Kleine-Weber, H. & Pohlmann, S. A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Mol. Cell 78, 779\u2013784.e775 (2020).","journal-title":"Mol. Cell"},{"key":"39147_CR17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","volume":"599","author":"P Mlcochova","year":"2021","unstructured":"Mlcochova, P. et al. SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature 599, 114\u2013119 (2021).","journal-title":"Nature"},{"key":"39147_CR18","doi-asserted-by":"publisher","first-page":"e20201181","DOI":"10.1084\/jem.20201181","volume":"217","author":"F Schmidt","year":"2020","unstructured":"Schmidt, F. et al. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses. J. Exp. Med. 217, e20201181 (2020).","journal-title":"J. Exp. Med."},{"key":"39147_CR19","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/s41392-022-01087-8","volume":"7","author":"C Fan","year":"2022","unstructured":"Fan, C. et al. Animal models for COVID-19: advances, gaps and perspectives. Sig. Transduct. Target. Ther. 7, 220 (2022).","journal-title":"Sig. Transduct. Target. Ther."},{"key":"39147_CR20","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1016\/S2666-5247(20)30089-6","volume":"1","author":"K Schlottau","year":"2020","unstructured":"Schlottau, K. et al. SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental transmission study. Lancet Microbe 1, e218\u2013e225 (2020).","journal-title":"Lancet Microbe"},{"key":"39147_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33632-y","volume":"13","author":"GT Barut","year":"2022","unstructured":"Barut, G. T. et al. The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype. Nat. Commun. 13, 5929 (2022).","journal-title":"Nat. Commun."},{"key":"39147_CR22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41586-021-03491-6","volume":"594","author":"L Braga","year":"2021","unstructured":"Braga, L. et al. Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia. Nature 594, 88\u201393 (2021).","journal-title":"Nature"},{"key":"39147_CR23","doi-asserted-by":"publisher","first-page":"103104","DOI":"10.1016\/j.ebiom.2020.103104","volume":"61","author":"R Bussani","year":"2020","unstructured":"Bussani, R. et al. Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology. EBioMedicine 61, 103104 (2020).","journal-title":"EBioMedicine"},{"key":"39147_CR24","doi-asserted-by":"crossref","unstructured":"Arora, P. et al. SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies. Cell Host Microbe 30, 1103\u20131111 (2022).","DOI":"10.1016\/j.chom.2022.04.017"},{"key":"39147_CR25","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.chom.2022.01.006","volume":"30","author":"A Escalera","year":"2022","unstructured":"Escalera, A. et al. Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission. Cell Host Microbe 30, 373\u2013387.e377 (2022).","journal-title":"Cell Host Microbe"},{"key":"39147_CR26","doi-asserted-by":"publisher","first-page":"109292","DOI":"10.1016\/j.celrep.2021.109292","volume":"35","author":"B Meng","year":"2021","unstructured":"Meng, B. et al. Recurrent emergence of SARS-CoV-2 spike deletion H69\/V70 and its role in the Alpha variant B.1.1.7. Cell Rep. 35, 109292 (2021).","journal-title":"Cell Rep."},{"key":"39147_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41586-021-03291-y","volume":"592","author":"SA Kemp","year":"2021","unstructured":"Kemp, S. A. et al. SARS-CoV-2 evolution during treatment of chronic infection. Nature 592, 277\u2013282 (2021).","journal-title":"Nature"},{"key":"39147_CR28","doi-asserted-by":"publisher","first-page":"104270","DOI":"10.1016\/j.ebiom.2022.104270","volume":"84","author":"A Aggarwal","year":"2022","unstructured":"Aggarwal, A. et al. SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern. EBioMedicine 84, 104270 (2022).","journal-title":"EBioMedicine"},{"key":"39147_CR29","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41564-021-00908-w","volume":"6","author":"TP Peacock","year":"2021","unstructured":"Peacock, T. P. et al. The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets. Nat Microbiol 6, 899\u2013909 (2021).","journal-title":"Nat Microbiol"},{"key":"39147_CR30","doi-asserted-by":"publisher","first-page":"e106501","DOI":"10.15252\/embj.2020106501","volume":"40","author":"G Shi","year":"2021","unstructured":"Shi, G. et al. Opposing activities of IFITM proteins in SARS-CoV-2 infection. EMBO J. 40, e106501 (2021).","journal-title":"EMBO J."},{"key":"39147_CR31","doi-asserted-by":"crossref","unstructured":"Winstone, H. et al. The polybasic cleavage site in SARS-CoV-2 spike modulates viral sensitivity to type I interferon and IFITM2. J. Virol. 95, e02422-20 (2021).","DOI":"10.1128\/JVI.02422-20"},{"key":"39147_CR32","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41586-022-05482-7","volume":"612","author":"R Uraki","year":"2022","unstructured":"Uraki, R. et al. Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents. Nature 612, 540\u2013545 (2022).","journal-title":"Nature"},{"key":"39147_CR33","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2022.2161422","volume":"12","author":"H Xia","year":"2023","unstructured":"Xia, H. et al. Cross-neutralization and viral fitness of SARS-CoV-2 Omicron sublineages. Emerg. Microbes Infect. 12, e2161422 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"39147_CR34","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1016\/j.cell.2022.09.018","volume":"185","author":"I Kimura","year":"2022","unstructured":"Kimura, I. et al. Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5. Cell 185, 3992\u20134007.e3916 (2022).","journal-title":"Cell"},{"key":"39147_CR35","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.chom.2022.10.003","volume":"30","author":"A Saito","year":"2022","unstructured":"Saito, A. et al. Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant. Cell Host Microbe 30, 1540\u20131555.e1515 (2022).","journal-title":"Cell Host Microbe"},{"key":"39147_CR36","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ijid.2022.11.024","volume":"127","author":"MA Davies","year":"2022","unstructured":"Davies, M. A. et al. Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa. Int. J. Infect. Dis. 127, 63\u201368 (2022).","journal-title":"Int. J. Infect. Dis."},{"key":"39147_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33614-0","volume":"13","author":"N Wolter","year":"2022","unstructured":"Wolter, N. et al. Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa. Nat. Commun. 13, 5860 (2022).","journal-title":"Nat. Commun."},{"key":"39147_CR38","doi-asserted-by":"crossref","unstructured":"Hansen, C. H. et al. Risk of reinfection, vaccine protection, and severity of infection with the BA.5 omicron subvariant: a nation-wide population-based study in Denmark. Lancet Infect. Dis. 23, 167\u2013176 (2022).","DOI":"10.1016\/S1473-3099(22)00595-3"},{"key":"39147_CR39","doi-asserted-by":"crossref","unstructured":"Russell, S. L. et al. Clinical severity of Omicron sub-variants BA.1, BA.2 and BA.5 in a population-based cohort study in British Columbia, Canada. J. Med. Virol. 95, e28423 (2022).","DOI":"10.1002\/jmv.28423"},{"key":"39147_CR40","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1016\/j.cell.2021.03.036","volume":"184","author":"M Hoffmann","year":"2021","unstructured":"Hoffmann, M. et al. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies. Cell 184, 2384\u20132393.e2312 (2021).","journal-title":"Cell"},{"key":"39147_CR41","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271\u2013280.e278 (2020).","journal-title":"Cell"},{"key":"39147_CR42","doi-asserted-by":"publisher","first-page":"e0189073","DOI":"10.1371\/journal.pone.0189073","volume":"12","author":"C Brinkmann","year":"2017","unstructured":"Brinkmann, C. et al. The glycoprotein of vesicular stomatitis virus promotes release of virus-like particles from tetherin-positive cells. PLoS ONE 12, e0189073 (2017).","journal-title":"PLoS ONE"},{"key":"39147_CR43","doi-asserted-by":"publisher","first-page":"e25858","DOI":"10.1371\/journal.pone.0025858","volume":"6","author":"M Berger Rentsch","year":"2011","unstructured":"Berger Rentsch, M. & Zimmer, G. A vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferon. PLoS ONE 6, e25858 (2011).","journal-title":"PLoS ONE"},{"key":"39147_CR44","doi-asserted-by":"publisher","first-page":"e210","DOI":"10.1016\/S2666-5247(21)00027-6","volume":"2","author":"S Schroeder","year":"2021","unstructured":"Schroeder, S. et al. Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics. Lancet Microbe 2, e210\u2013e218 (2021).","journal-title":"Lancet Microbe"},{"key":"39147_CR45","doi-asserted-by":"publisher","first-page":"e2102983118","DOI":"10.1073\/pnas.2102983118","volume":"118","author":"LR Wong","year":"2021","unstructured":"Wong, L. R. et al. Middle East respiratory syndrome coronavirus Spike protein variants exhibit geographic differences in virulence. Proc. Natl Acad. Sci. USA 118, e2102983118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"39147_CR46","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1111\/tbed.13926","volume":"68","author":"K Wernike","year":"2021","unstructured":"Wernike, K. et al. Multi-species ELISA for the detection of antibodies against SARS-CoV-2 in animals. Transbound Emerg. Dis. 68, 1779\u20131785 (2021).","journal-title":"Transbound Emerg. Dis."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-39147-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-39147-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-39147-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T16:03:44Z","timestamp":1686672224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-39147-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,13]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["39147"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-39147-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,13]]},"assertion":[{"value":"4 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3500"}}